CLINICAL EVALUATION OF CEFPROZIL IN CHILDREN

Cefprozil (CFPZ, BMY-28100), a new oral cephalosporin, was evaluated for its efficacy and safety in 42 children with bacterial infections (Table 1), and the following results were obtained. 1. CFPZ was administered in 3 or 4 divided doses at daily dosages ranging from 15.3 to 60.0mg/kg to 42 patient...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Japanese journal of antibiotics 1992/12/25, Vol.45(12), pp.1622-1634
Hauptverfasser:	MOCHIZUKI, YASUHIRO, KANAZASHI, SHUICHI, HATA, DAISUKE, OHKUBO, HIDEO, ITOH, SETSUKO, MAYUMI, MITSUFUMI, MIKAWA, HARUKI
Format:	Artikel
Sprache:	jpn
Schlagworte:	Administration, Oral Age Factors Bacteria - drug effects Bacteria - isolation & purification Bacterial Infections - drug therapy Bacterial Infections - microbiology Cefprozil Cephalosporins - administration & dosage Cephalosporins - pharmacology Cephalosporins - therapeutic use Child Child, Preschool Drug Evaluation Drug Resistance, Microbial Female Humans Infant Male
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!